Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 2
1994 3
1995 3
1996 6
1997 3
1998 4
1999 6
2000 6
2001 5
2002 2
2003 2
2004 6
2005 7
2006 4
2007 5
2008 4
2009 1
2010 3
2011 2
2013 3
2014 4
2015 3
2016 4
2017 4
2018 2
2020 3
2021 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18074471

101 results

Results by year

Filters applied: . Clear all
Page 1
Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study.
Werdan K, Pilz G, Bujdoso O, Fraunberger P, Neeser G, Schmieder RE, Viell B, Marget W, Seewald M, Walger P, Stuttmann R, Speichermann N, Peckelsen C, Kurowski V, Osterhues HH, Verner L, Neumann R, Müller-Werdan U; Score-Based Immunoglobulin Therapy of Sepsis (SBITS) Study Group. Werdan K, et al. Crit Care Med. 2007 Dec;35(12):2693-2701. Crit Care Med. 2007. PMID: 18074471 Clinical Trial.
Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome--the ESSICS study.
Werdan K, Pilz G, Müller-Werdan U, Maas Enriquez M, Schmitt DV, Mohr FW, Neeser G, Schöndube F, Schäfers HJ, Haverich A, Fraunberger P, Andersson J, Kreuzer E, Thijs LG; Early Supplemental Severe SIRS Treatment With IVIG in Score-Identified High-Risk Patients After Cardiac Surgery (ESSICS) Study Group. Werdan K, et al. Crit Care Med. 2008 Mar;36(3):716-23. doi: 10.1097/01.CCM.0B013E3181611F62F. Crit Care Med. 2008. PMID: 18091548 Clinical Trial.
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.
Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, Zimmerli W, Anderson P, Reynaert M, Lew D, Lesslauer W, Passe S, Cooper P, Burdeska A, Modi M, Leighton A, Salgo M, Van der Auwera P; Lenercept Study Group. Abraham E, et al. Crit Care Med. 2001 Mar;29(3):503-10. doi: 10.1097/00003246-200103000-00006. Crit Care Med. 2001. PMID: 11373411 Clinical Trial.
Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R. Angstwurm MW, et al. Crit Care Med. 2007 Jan;35(1):118-26. doi: 10.1097/01.CCM.0000251124.83436.0E. Crit Care Med. 2007. PMID: 17095947 Clinical Trial.
Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock.
Iizuka Y, Sanui M, Sasabuchi Y, Lefor AK, Hayakawa M, Saito S, Uchino S, Yamakawa K, Kudo D, Takimoto K, Mayumi T, Azuhata T, Ito F, Yoshihiro S, Hayakawa K, Nakashima T, Ogura T, Noda E, Nakamura Y, Sekine R, Yoshikawa Y, Sekino M, Ueno K, Okuda Y, Watanabe M, Tampo A, Saito N, Kitai Y, Takahashi H, Kobayashi I, Kondo Y, Matsunaga W, Nachi S, Miike T, Takahashi H, Takauji S, Umakoshi K, Todaka T, Kodaira H, Andoh K, Kasai T, Iwashita Y, Arai H, Murata M, Yamane M, Shiga K, Hori N. Iizuka Y, et al. Crit Care. 2017 Jul 13;21(1):181. doi: 10.1186/s13054-017-1764-4. Crit Care. 2017. PMID: 28701223 Free PMC article.
101 results